SEPTEMBERASIA BUSINESS OUTLOOK4 Vol 01 · Issue 2 - 1 · SEPTEMBER, 2022 Publisher Alok Chaturvedi Managing Editor Emmanuel Chiristi Das Editorial Avinash Barik Heena Kousar Hima P M Samatha SP Manager - DesignPrabhu Dutta A.R.N RayEditorial queries editor@asiabusinessoutlook.comSales Team Vinson Raj Ezekiah S. EdwardG Krishna S ShajilalTo subscribeVisit www.asiabusinessoutlook.com/subscribe/ or send emailto subscription@asiabusinessoutlook.comMagazine Price is $50 per issue.Editor Alok ChaturvediPrinted and Published By Alok Chaturvedi on behalf of Siliconmedia Technologies Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Copyright © 2022 Siliconmedia Technologies Pvt. Ltd. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.GM Sales and Marketing Nagendra Kumar KCirculation Manager P MagendranEditorialSmall and medium-sized businesses and well-funded startups that are inventing quickly dominate the medical device sector. Pharma and medtech businesses are developing solutions that offer a higher quality of life, more accurate diagnoses, and better patient outcomes as a result of the developments in data science and AI. Several small businesses lack experienced full-time staff members who can guide them through the difficult route to market, which includes many difficulties like regulatory compliance, clinical evaluation, literature searches, and more.Your products are literally affecting lives in a fiercely competitive business. A top priority must be given to promptly launching your medical gadgets on the market. But passing audits and adhering to all the FDA or ISO rules takes time and is frustrating. When you have so much bureaucracy to get through, how can you concentrate on what actually matters--launching your product?Medical device and pharmaceutical/biotech companies need to make sure they always abide by all applicable laws in the locations where they do business. This is essential to avoid pricey legal difficulties as well as to keep the public's trust. However, given the numerous and intricate web of governmental organisations that cover all the regions in which these businesses operate, this can be difficult. At the same time, rapid urbanisation, rising consumer spending, and predicted growth rates all point to stronger opportunities for international makers of pharmaceuticals or medical equipment looking to expand into the Indian subcontinent. The Central Drug Standards Control Organization oversees the pharmaceutical and medical device regulatory framework in India (CDSCO). The Indian pharmaceutical market appears to be lucrative, but the region's tightening restrictions may make it difficult for foreign producers to obtain simplified market authorizations through product registrations and health authority clearances. A regulatory consultants can turn the tables around for a manufacturer to significantly catapult their time-to-market. Emmanuel Christi DasManaging Editoreditor@asiabusinessoutlook.comThe Urgent Dilemma of Life Saving Products Design I. Dinesh Kumar Tushar Das
< Page 3 | Page 5 >